JP2017502985A5 - - Google Patents

Download PDF

Info

Publication number
JP2017502985A5
JP2017502985A5 JP2016546484A JP2016546484A JP2017502985A5 JP 2017502985 A5 JP2017502985 A5 JP 2017502985A5 JP 2016546484 A JP2016546484 A JP 2016546484A JP 2016546484 A JP2016546484 A JP 2016546484A JP 2017502985 A5 JP2017502985 A5 JP 2017502985A5
Authority
JP
Japan
Prior art keywords
group
liposome composition
cyclodextrin
functional group
liposome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016546484A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017502985A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2015/011342 external-priority patent/WO2015108932A1/en
Publication of JP2017502985A publication Critical patent/JP2017502985A/ja
Publication of JP2017502985A5 publication Critical patent/JP2017502985A5/ja
Pending legal-status Critical Current

Links

JP2016546484A 2014-01-14 2015-01-14 修飾シクロデキストリン複合体をカプセル化するリポソーム組成物およびその使用 Pending JP2017502985A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461927233P 2014-01-14 2014-01-14
US61/927,233 2014-01-14
PCT/US2015/011342 WO2015108932A1 (en) 2014-01-14 2015-01-14 Liposome compositions encapsulating modified cyclodextrin complexes and uses thereof

Publications (2)

Publication Number Publication Date
JP2017502985A JP2017502985A (ja) 2017-01-26
JP2017502985A5 true JP2017502985A5 (enExample) 2018-02-22

Family

ID=53543384

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016546484A Pending JP2017502985A (ja) 2014-01-14 2015-01-14 修飾シクロデキストリン複合体をカプセル化するリポソーム組成物およびその使用

Country Status (8)

Country Link
US (2) US20180161274A1 (enExample)
EP (1) EP3094313A4 (enExample)
JP (1) JP2017502985A (enExample)
CN (1) CN106659683A (enExample)
AU (1) AU2015206628A1 (enExample)
CA (1) CA2936963A1 (enExample)
HK (1) HK1231397A1 (enExample)
WO (1) WO2015108932A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3370712B1 (en) 2015-11-06 2025-02-19 The Johns Hopkins University 3-bromopyruvate for treating liver fibrosis
SG10202107836SA (en) * 2017-01-18 2021-08-30 Temasek Life Sciences Laboratory Ltd Hyperstabilized liposomes increase targeting of mitotic cells
CN108478533B (zh) * 2018-04-23 2020-12-08 滨州医学院 β环糊精-LPC脂质体制备方法及其作为药物载体的应用
CN112384226B (zh) * 2018-07-06 2024-06-28 丸大食品株式会社 含有缩醛磷脂的组合物
CN108853111B (zh) * 2018-08-07 2020-06-05 浙江大学 一种组合物在制备治疗吉非替尼肝脏毒性药物中的应用
CN111449187B (zh) * 2020-05-09 2022-10-14 扬州大学 一种布氏乳杆菌S-层蛋白修饰的香芹酚/β-环糊精脂质体及其制备方法和抗菌用途
EP4026945A1 (en) * 2021-01-07 2022-07-13 Calik Denim Tekstil San. Ve Tic. A.S. Encapsulated indigo
CN114113426B (zh) * 2021-12-27 2024-04-26 西安血氧生物技术有限公司 一种血红蛋白氧载体中磷脂的检测方法
CN115386262B (zh) * 2022-09-26 2023-05-12 杭州海维特化工科技有限公司 一种应用于汽车内饰装饰塑料膜的缓释香精和负离子的凹印水墨及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04500229A (ja) * 1988-08-31 1992-01-16 オーストレイリアン・コマーシヤル・リサーチ・アンド・デイベロツプメント・リミテツド 薬剤分配用及びクロマトグラフィー用の組成物及び方法
ES2036504A6 (es) * 1990-03-02 1993-05-16 Australian Commercial Research Procedimiento para preparar complejos de ciclodextrina.
AU6818094A (en) * 1993-04-22 1994-11-08 Depotech Corporation Cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use
HU213200B (en) * 1993-05-12 1997-03-28 Chinoin Gyogyszer Es Vegyeszet The cyclodextrin or cyclodextrin derivative cluster complexes of taxol, taxotere, or taxus, pharmaceutical preparations containing them and process for their production
DE19814815C2 (de) * 1998-04-02 2000-10-12 Gerhard Steffan Sterinverknüpfte, anionische Cyclodextrinderivate und deren Verwendung in Arzneimittelformulierungen
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
CN101653414B (zh) * 2008-08-19 2011-07-20 中国科学院上海药物研究所 多西他赛长循环固体脂质纳米粒及其制备方法
EP2415464B1 (en) * 2009-03-30 2017-05-10 Eisai R&D Management Co., Ltd. Method for producing liposome composition
CN102596178B (zh) * 2009-10-26 2014-12-03 石药集团中奇制药技术(石家庄)有限公司 具有磺丁基醚环糊精盐内水相的脂质体
CN102397248A (zh) * 2010-09-15 2012-04-04 万物(北京)医药科技发展有限公司 一种辛二酰苯胺异羟肟酸环糊精包合物脂质体
ES2770575T3 (es) * 2010-10-28 2020-07-02 Pacira Pharmaceuticals Inc Formulación de liberación sostenida de un fármaco antiinflamatorio no esteroideo
WO2012118376A1 (en) * 2011-03-01 2012-09-07 To-Bbb Holding B.V. Advanced active liposomal loading of poorly water-soluble substances
WO2014004651A1 (en) * 2012-06-26 2014-01-03 The Johns Hopkins University Multifunctional tunable biomaterials for tissue engineering
WO2014121235A2 (en) * 2013-02-01 2014-08-07 Zoneone Pharma, Inc. Transformation of drug cyclodextrin complex compositions into compositions of mixtures of lipid vesicle encapsulated drug and cyclodextrin drug complexes

Similar Documents

Publication Publication Date Title
JP2017502985A5 (enExample)
Mohamed et al. PEGylated liposomes: immunological responses
Vogus et al. A hyaluronic acid conjugate engineered to synergistically and sequentially deliver gemcitabine and doxorubicin to treat triple negative breast cancer
Boztas et al. Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells
Zhang et al. A copper-mediated disulfiram-loaded pH-triggered PEG-shedding TAT peptide-modified lipid nanocapsules for use in tumor therapy
Pan et al. Mesoporous silica nanoparticles (MSNs)-based organic/inorganic hybrid nanocarriers loading 5-Fluorouracil for the treatment of colon cancer with improved anticancer efficacy
Fernandez et al. N-Succinyl-(β-alanyl-l-leucyl-l-alanyl-l-leucyl) doxorubicin: an extracellularly tumor-activated prodrug devoid of intravenous acute toxicity
HRP20210351T1 (hr) Spojevi prostaciklina
WO2017223085A3 (en) Compositions and methods for delivery of biomacromolecule agents
Muppidi et al. PEGylated liposome encapsulation increases the lung tissue concentration of vancomycin
ES2658953T3 (es) Combinaciones y usos de los mismos
JP2017502984A5 (enExample)
ES2664584B2 (es) Nanoparticulas con interiores protegidos, y métodos de uso de las mismas
WO2014014613A3 (en) Self-assembling peptides, peptide nanostructures and uses thereof
JP2015523355A5 (enExample)
WO2005072061A3 (en) Conjugates for cancer therapy and diagnosis
JP2013509389A5 (enExample)
Qiao et al. Nanostructured peptidotoxins as natural pro-oxidants induced cancer cell death via amplification of oxidative stress
WO2013188210A3 (en) Treatment of side effects associated with parkinson's disease treatments
Zhong et al. Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles
Liu et al. Myricetin oligomer triggers multi-receptor mediated penetration and autophagic restoration of blood-brain barrier for ischemic stroke treatment
FI3511004T3 (fi) Yhdistelmävalmisteita syövän hoitoon
Deshmukh et al. A series of α-amino acid ester prodrugs of camptothecin: in vitro hydrolysis and A549 human lung carcinoma cell cytotoxicity
JP2018526460A5 (enExample)
FI3071563T3 (fi) Syövän vastaisia aineita ja niiden valmistus